Surgical Needles & Scissors

We are leaders in the market for providing best range of Trastuzumab Intravenous Infusion

Trastuzumab Intravenous Infusion

Application Clinic, Hospital
Usage Used for Cancer Treatment
Dosage As per Doctor's Prescription
Storage Cool and Dry Place
Best Before 36 Months from Manufacturing

FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease.

Sacituzumab govitecan (Trodelvy): In the case of this ADC, the monoclonal antibody part attaches to the Trop-2 protein on breast cancer cells and brings a chemo drug, similar to irinotecan, directly to them. (Some breast cancer cells have too much Trop-2, which helps them grow and spread quickly.)

This antibody-drug conjugate can be used by itself to treat advanced TNBC, after at least 2 other chemo regimens have been tried. This drug is given in a vein (IV) weekly for 2 weeks, followed by one week off, then restarted.

View Complete Details

Ask Latest Price & Details

Tell Us What are you looking for? Will call you back